These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 11098928)

  • 41. Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients.
    Honda K; Nitta K; Horita S; Tsukada M; Itabashi M; Nihei H; Akiba T; Oda H
    Adv Perit Dial; 2003; 19():169-75. PubMed ID: 14763056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current Status of Peritoneal Dialysis in Japan.
    Ito Y; Tawada M; Tine S; Mizuno M; Suzuki Y; Katsuno T
    Contrib Nephrol; 2018; 196():123-128. PubMed ID: 30041216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Encapsulating peritoneal sclerosis: what have we learned?
    Goodlad C; Brown EA
    Semin Nephrol; 2011 Mar; 31(2):183-98. PubMed ID: 21439432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The plasma leak-to-response hypothesis: a working hypothesis on the pathogenesis of encapsulating peritoneal sclerosis after long-term peritoneal dialysis treatment.
    Nakayama M
    Perit Dial Int; 2005 Apr; 25 Suppl 4():S71-6. PubMed ID: 16300275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Encapsulating peritoneal sclerosis in Japan.
    Maruyama Y; Nakayama M
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S201-4. PubMed ID: 18552256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bloody ascites in a patient after transfer from peritoneal dialysis to hemodialysis.
    Pollock CA
    Semin Dial; 2003; 16(5):406-10. PubMed ID: 12969397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients.
    Hoshii S; Honda M; Itami N; Oh S; Matsumura C; Moriya S; Mori M; Hatae K; Ito Y; Karashima S
    Pediatr Nephrol; 2000 Apr; 14(4):275-9. PubMed ID: 10775068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis.
    Otsuka Y; Nakayama M; Ikeda M; Sherif AM; Yokoyama K; Yamamoto H; Kawaguchi Y
    Clin Exp Nephrol; 2005 Dec; 9(4):315-319. PubMed ID: 16362159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Encapsulating peritoneal sclerosis].
    Torres R; Ebner P; Sanhueza ME; Alvo M; Segovia E; Segura P
    Rev Med Chil; 2017 Jan; 145(1):41-48. PubMed ID: 28393968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stability of the peritoneal membrane in long-term peritoneal dialysis patients.
    Selgas R; Bajo MA; Paiva A; Del Peso G; Diaz C; Aguilera A; Hevia C
    Adv Ren Replace Ther; 1998 Jul; 5(3):168-78. PubMed ID: 9686627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Encapsulating Peritoneal Sclerosis.
    Alston H; Fan S; Nakayama M
    Semin Nephrol; 2017 Jan; 37(1):93-102. PubMed ID: 28153198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Dutch EPS Registry: increasing the knowledge of encapsulating peritoneal sclerosis.
    Korte MR; Boeschoten EW; Betjes MG;
    Neth J Med; 2009 Sep; 67(8):359-62. PubMed ID: 19767668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature.
    Afthentopoulos IE; Passadakis P; Oreopoulos DG; Bargman J
    Adv Ren Replace Ther; 1998 Jul; 5(3):157-67. PubMed ID: 9686626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Encapsulating peritoneal sclerosis in an Italian center: thirty year experience.
    Vizzardi V; Sandrini M; Zecchini S; Ravera S; Manili L; Cancarini G
    J Nephrol; 2016 Apr; 29(2):259-267. PubMed ID: 26521254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study.
    Kawanishi H; Kawaguchi Y; Fukui H; Hara S; Imada A; Kubo H; Kin M; Nakamoto M; Ohira S; Shoji T
    Am J Kidney Dis; 2004 Oct; 44(4):729-37. PubMed ID: 15384025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiology of encapsulating peritoneal sclerosis in Japan.
    Kawanishi H; Moriishi M
    Perit Dial Int; 2005 Apr; 25 Suppl 4():S14-8. PubMed ID: 16300268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
    Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
    Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical peritonitis in patients on peritoneal dialysis.
    Shrestha BM; Brown P; Wilkie M
    Perit Dial Int; 2008; 28(4):331-4. PubMed ID: 18556371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosis.
    Sampimon DE; Coester AM; Struijk DG; Krediet RT
    Nephrol Dial Transplant; 2011 Jan; 26(1):291-8. PubMed ID: 20566569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of renin-angiotensin system inhibition on regression of encapsulating peritoneal sclerosis.
    Bozkurt D; Cetin P; Sipahi S; Hur E; Nar H; Ertilav M; Sezak M; Duman S
    Perit Dial Int; 2008 Nov; 28 Suppl 5():S38-42. PubMed ID: 19008539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.